Surgical Revascularization in Older Adults with Ischemic Cardiomyopathy
With the totality of data supporting coronary artery bypass graft (CABG) for mortality benefit, symptomatic angina, and quality of life improvement, CABG should be a class I indication for patients with ischemic cardiomyopathy and severe left ventricular dysfunction. As the population ages and more patients are referred for CABG, a careful risk-benefit assessment should be an important part of the consideration regarding revascularization strategies. A heart team approach is critical to arrive at the best decision for each patient. Age, alone, should not be a contraindication because there are data to support a reduction in cardiovascular mortality with CABG in older patients.
Khera, S., & Panza, J. A. (2017). Surgical Revascularization in Older Adults with Ischemic Cardiomyopathy. Heart Failure Clinics, 13 (3), 571-580. https://doi.org/10.1016/j.hfc.2017.02.010
Originally published in Heart Failure Clinics. The original material can be found here.